Lamivudine useful against hepatitis B-HIV co-infection.
Prescott
L M
LM
D000998:Antiviral Agents / Q000627:therapeutic use*; D018791:CD4 Lymphocyte Count; D004279:DNA, Viral / Q000032:analysis; D015658:HIV Infections / Q000150:complications / Q000188:drug therapy*; D006509:Hepatitis B / Q000150:complications / Q000188:drug therapy*; D006515:Hepatitis B virus / Q000235:genetics / Q000302:isolation & purification / Q000502:physiology; D006801:Humans; D019259:Lamivudine; D014779:Virus Replication; D016047:Zalcitabine / Q000031:analogs & derivatives / Q000627:therapeutic use*; D015215:Zidovudine / Q000627:therapeutic use
D000998:Antiviral Agents; D004279:DNA, Viral; D019259:Lamivudine; D015215:Zidovudine; D016047:Zalcitabine